Periodontitis is a severe form of periodontal disease that damages the tissues and bone supporting the teeth. The World Health Organization estimates about 1 billion people worldwide live with a severe periodontal condition. Prior research has associated periodontal disease with an increased risk of systemic conditions, including cardiovascular disease. A recent study presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions 2026 examined whether the oral pathogen Porphyromonas gingivalis (P. gingivalis) might contribute to calcific aortic valve stenosis (CAVS), a common valvular disease in older adults that can restrict cardiac outflow and currently has no proven medical therapy to prevent progression.
The researchers used multiple approaches to explore a potential biological link between periodontitis and CAVS. Their methods included analysis of human aortic valve tissue and experiments in a mouse model. The mouse experiments involved repeated systemic exposure to live P. gingivalis to model chronic or recurrent bacteremia that can occur in people with poor oral health during routine activities such as brushing and chewing. The source article reported these approaches but did not provide specific numeric details about sample size, exposure protocols, or statistical analyses in this summary.
In the animal model, repeated exposure to live P. gingivalis resulted in detectable bacterial accumulation within the aortic valves and was associated with increased valve calcification and features consistent with aortic stenosis. The investigators also reported detection of P. gingivalis DNA in calcified human aortic valves in previous studies, and their experimental data suggest the relationship may be more than incidental colonization. The study therefore supports the possibility that systemic exposure to periodontal pathogens can actively contribute to valve calcification in this model.
The research team observed that preventive antibiotic treatment reduced bacterial accumulation in aortic valves and attenuated valve calcification in their experimental system. However, the authors cautioned that these findings from animal models should not be interpreted as evidence that antibiotics can prevent CAVS in humans. The source article emphasizes that the study was preclinical and that translation to human treatment requires further validation. Detailed information about antibiotic regimens, timing, or resistance considerations was not reported in the summary.
Investigators highlighted chronic inflammation as a central driver of valve calcification. They noted plans to investigate infection-related inflammatory pathways further, with particular interest in IL-1β signaling as a potential mechanism linking infection to calcific remodeling of the aortic valve. The authors propose that targeting such inflammatory pathways could represent a strategy for preventing or slowing CAVS progression, but clinical proof is currently lacking.
Cardiology and dental experts not involved in the study commented on the findings. A cardiologist and lipidologist noted the results align with established associations between periodontal disease, chronic inflammation, and atherosclerosis. Clinicians emphasized that while the link to valve disease is plausible, evidence of causation in humans remains unproven. An oral and maxillofacial surgeon reiterated the systemic implications of oral inflammation and described the study as an early but plausible demonstration of a pathway from periodontal bacteria to valve calcification. An interventional cardiologist highlighted the need for larger, long-term observational studies and randomized trials to determine whether aggressive periodontal treatment, targeted antibiotics, or anti-inflammatory therapies can affect CAVS progression in diverse human populations.
The American Academy of Periodontology recommends practical measures to prevent periodontal disease, discussed in the source article. These include:
The source article and interviewed periodontists stress that periodontal disease is a chronic inflammatory condition that affects more than the mouth, and that periodontists are trained to diagnose and treat this inflammation.
The investigators stated their next steps include validating these findings in larger clinical cohorts and exploring whether interventions that target infection-related inflammation, including IL-1β inhibition, may prevent or slow calcific aortic valve disease. Experts called for large, long-term observational studies to establish association and potential causation in humans, followed by interventional trials if warranted.
Note on reported details
This summary is based on the source article’s report of a conference presentation and related commentary. The source did not report full methodological specifics, numeric results, or statistical data from the study; those details reportedly were part of the conference presentation and will require review of the full study or subsequent publications for complete evaluation.